Biomarin Pharmaceutical Inc (NASDAQ: BMRN) kicked off on Tuesday, down -3.90% from the previous trading day, before settling in for the closing price of $62.06.
Biomarin Pharmaceutical Inc (NASDAQ: BMRN) flaunted slowness of -1.54% at $62.71, as the Stock market unbolted on Thursday, before settling in for the price of
On Monday, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) opened lower -0.51% from the last session, before settling in for the closing price of $63.30. Price fluctuations
Witnessing the stock’s movement on the chart, on Wednesday, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) set off with pace as it heaved 0.72% to $61.94, before
On Thursday, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) was 0.60% up from the session before settling in for the closing price of $58.82. A 52-week range
On Monday, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) was 5.02% up from the session before settling in for the closing price of $56.82. A 52-week range
As on Thursday, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) started slowly as it slid -5.23% to $56.32, before settling in for the price of $59.43 at
Biomarin Pharmaceutical Inc (NASDAQ: BMRN) kicked off on Friday, down -10.70% from the previous trading day, before settling in for the closing price of $67.48.
On Tuesday, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) opened lower -3.89% from the last session, before settling in for the closing price of $70.69. Price fluctuations
On Tuesday, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) was -0.64% drop from the session before settling in for the closing price of $71.99. A 52-week range
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
